• Joseph BikowskiEmail author


Rosacea, a chronic, inflammatory skin condition, is estimated to affect ten million Americans [1]. Characterized by a centrofacial distribution of acneiform papules and pustules, diffuse erythema, and frequently but not always telangiectases [2], rosacea is a highly visible disease that has been associated with negative influences on affected individuals’ quality of life [3, 4]. Although the disease is generally thought to be of primarily cosmetic consequence, patients have reported stinging and pain associated with rosacea [5], and functional impairments may result from severe rhinophyma [6]. A number of treatment options are available—both topical and systemic—for the management of rosacea in its various presentations. With a proper diagnosis, a rational therapeutic strategy, and supportive skin care and patient education, control of rosacea is possible.


Azelaic Acid Seborrheic Dermatitis Facial Erythema Vermillion Border Topical Metronidazole 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Yamasaki K, Gallo RL. The molecular pathology of rosacea. J Dermatol Sci. 2009;55:77–81.PubMedCrossRefGoogle Scholar
  2. 2.
    Diamantis S, Waldorf HA. Rosacea: clinical presentation and pathophysiology. J Drugs Dermatol. 2006;5:8–12.PubMedGoogle Scholar
  3. 3.
    Balkrishnan R, McMichael AJ, Hu JY, Camacho FT, Shew KR, Bouloc A, et al. Correlates of health-related quality of life in women with severe facial blemishes. Int J Dermatol. 2006;45:111–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Aksoy B, Altaykan-Hapa A, Egemen D, Karagöz F, Atakan N. The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities. Br J Dermatol. 2010;163:719–25.PubMedCrossRefGoogle Scholar
  5. 5.
    Wilkin J, Dahl M, Detmar M, et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2004;50:907–12.PubMedCrossRefGoogle Scholar
  6. 6.
    Hoasjoe DK, Stucker FJ. Rhinophyma: review of pathophysiology and treatment. J Otolaryngol. 1995;24:51–6.PubMedGoogle Scholar
  7. 7.
    Wollina U. Rosacea and rhinophyma in the elderly. Clin Dermatol. 2011;29:61–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Feldman SR, Hollar CB, Gupta AK, Fleischer Jr AB. Women commonly seek care for rosacea: dermatologists frequently provide the care. Cutis. 2001;68:156–60.PubMedGoogle Scholar
  9. 9.
    Elsaie ML, Choudhary S. Updates on the pathophysiology and management of acne rosacea. Postgrad Med. 2009;121:178–86.PubMedCrossRefGoogle Scholar
  10. 10.
    Elewski BE, Draelos Z, Dréno B, Jansen T, Layton A, Picardo M. Rosacea-global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group. J Eur Acad Dermatol Venereol. 2011;25:188–200.PubMedCrossRefGoogle Scholar
  11. 11.
    Jones DA. Rosacea, reactive oxygen species, and azelaic acid. J Clin Aesthet Dermatol. 2009;2:26–30.PubMedGoogle Scholar
  12. 12.
    Marks R. The enigma of rosacea. J Dermatolog Treat. 2007;18(6):326–8.PubMedCrossRefGoogle Scholar
  13. 13.
    McAleer MA, Fitzpatrick P, Powell FC. Papulopustular rosacea: prevalence and relationship to photodamage. J Am Acad Dermatol. 2010;63:33–9.PubMedCrossRefGoogle Scholar
  14. 14.
    National Rosacea Society website. Accessed 21 Sept 2011.
  15. 15.
    Oltz M, Check J. Rosacea and its ocular manifestations. Optometry. 2011;82:92–103.PubMedCrossRefGoogle Scholar
  16. 16.
    Ghanem VC, Mehra N, Wong S, Mannis MJ. The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics. Cornea. 2003;22:230–3.PubMedCrossRefGoogle Scholar
  17. 17.
    Lipozencic J, Ljubojevic S. Perioral dermatitis. Clin Dermatol. 2011;29:157–61.PubMedCrossRefGoogle Scholar
  18. 18.
    Ljubojeviae S, Basta-Juzbasiae A, Lipozenèiae J. Steroid dermatitis resembling rosacea: aetiopathogenesis and treatment. J Eur Acad Dermatol Venereol. 2002;16:121–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Zhao YE, Wu LP, Peng Y, Cheng H. Retrospective analysis of the association between Demodex infestation and rosacea. Arch Dermatol. 2010;146:896–902.PubMedCrossRefGoogle Scholar
  20. 20.
    Bikowski JB, Del Rosso JQ. Demodex dermatitis: a retrospective analysis of clinical diagnosis and successful treatment with topical crotamiton. J Clin Aesthet Dermatol. 2009;2:20–5.PubMedGoogle Scholar
  21. 21.
    Draelos ZD. Treating beyond the histology of rosacea. Cutis. 2004;74(3 Suppl):28–31. 32–34.PubMedGoogle Scholar
  22. 22.
    Bikowski J. The use of therapeutic moisturizers in various dermatologic disorders. Cutis. 2001;68(5 Suppl):3–11.PubMedGoogle Scholar
  23. 23.
    Conde JF, Yelverton CB, Balkrishnan R, Fleischer Jr AB, Feldman SR. Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics. J Drugs Dermatol. 2007;6:495–8.PubMedGoogle Scholar
  24. 24.
    Del Rosso JQ, Baum EW, Draelos ZD, et al. Azelaic acid gel 15%: clinical versatility in the treatment of rosacea. Cutis. 2006;78(5 Suppl):6–19.PubMedGoogle Scholar
  25. 25.
    Del Rosso JQ, Bhatia N. Azelaic acid gel 15% in the management of papulopustular rosacea: a status report on available efficacy data and clinical application. Cutis. 2011;88:67–72.PubMedGoogle Scholar
  26. 26.
    van Zuuren EJ, Kramer S, Carter B, Graber MA, Fedorowicz Z. Interventions for rosacea. Cochrane Database Syst Rev. 2011;16:CD003262.Google Scholar
  27. 27.
    Bikowski JB. The pharmacologic therapy of rosacea: a paradigm shift in progress. Cutis. 2005;75(3):27–32.PubMedGoogle Scholar
  28. 28.
    Wolf Jr JE. Present and future rosacea therapy. Cutis. 2005;75(3 Suppl):4–7.PubMedGoogle Scholar
  29. 29.
    Kennedy Carney C, Cantrell W, Elewski BE. Rosacea: a review of current topical, systemic and light-based therapies. G Ital Dermatol Venereol. 2009;144:673–88.PubMedGoogle Scholar
  30. 30.
    Jansen T, Plewig G. Clinical and histological variants of rhinophyma, including nonsurgical treatment modalities. Facial Plast Surg. 1998;14:241–53.PubMedCrossRefGoogle Scholar
  31. 31.
    Park H, Del Rosso JQ. Use of oral isotretinoin in the management of rosacea. J Clin Aesthet Dermatol. 2011;4:54–61.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Bikowski Skin Care CenterSewickleyUSA

Personalised recommendations